{"id":"https://openalex.org/W2139155301","doi":"https://doi.org/10.1128/aac.47.4.1318-1323.2003","title":"Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects","display_name":"Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects","publication_year":2003,"publication_date":"2003-03-24","ids":{"openalex":"https://openalex.org/W2139155301","doi":"https://doi.org/10.1128/aac.47.4.1318-1323.2003","mag":"2139155301","pmid":"https://pubmed.ncbi.nlm.nih.gov/12654665","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/152488"},"language":"en","primary_location":{"id":"doi:10.1128/aac.47.4.1318-1323.2003","doi":"https://doi.org/10.1128/aac.47.4.1318-1323.2003","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.47.4.1318-1323.2003","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139155301"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC152488","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022335655","display_name":"Barry H. Dvorchik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97187500","display_name":"Cubist Pharmaceuticals (United States)","ror":"https://ror.org/02xwa6p02","country_code":"US","type":"company","lineage":["https://openalex.org/I97187500"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Barry H. Dvorchik","raw_affiliation_strings":["Cubist Pharmaceuticals, Inc., Lexington, Massachusetts","Cubist Pharmaceuticals Inc, Lexington, Massachusetts 02421, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cubist Pharmaceuticals, Inc., Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]},{"raw_affiliation_string":"Cubist Pharmaceuticals Inc, Lexington, Massachusetts 02421, USA","institution_ids":["https://openalex.org/I97187500"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Brazier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97187500","display_name":"Cubist Pharmaceuticals (United States)","ror":"https://ror.org/02xwa6p02","country_code":"US","type":"company","lineage":["https://openalex.org/I97187500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Brazier","raw_affiliation_strings":["Cubist Pharmaceuticals, Inc., Lexington, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cubist Pharmaceuticals, Inc., Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103560449","display_name":"Michael F. DeBruin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97187500","display_name":"Cubist Pharmaceuticals (United States)","ror":"https://ror.org/02xwa6p02","country_code":"US","type":"company","lineage":["https://openalex.org/I97187500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael F. DeBruin","raw_affiliation_strings":["Cubist Pharmaceuticals, Inc., Lexington, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cubist Pharmaceuticals, Inc., Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064245686","display_name":"Robert D. Arbeit","orcid":"https://orcid.org/0000-0002-7013-3269","observed_orcids":["https://orcid.org/0000-0002-7013-3269"]},"institutions":[{"id":"https://openalex.org/I97187500","display_name":"Cubist Pharmaceuticals (United States)","ror":"https://ror.org/02xwa6p02","country_code":"US","type":"company","lineage":["https://openalex.org/I97187500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert D. Arbeit","raw_affiliation_strings":["Cubist Pharmaceuticals, Inc., Lexington, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cubist Pharmaceuticals, Inc., Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5022335655"],"corresponding_institution_ids":["https://openalex.org/I97187500"],"apc_list":null,"apc_paid":null,"fwci":9.5893,"has_fulltext":false,"cited_by_count":358,"citation_normalized_percentile":{"value":0.98730083,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"47","issue":"4","first_page":"1318","last_page":"1323"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daptomycin","display_name":"daptomycin","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9079999923706055},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5889999866485596},{"id":"https://openalex.org/keywords/lipopeptide-antibiotics","display_name":"lipopeptide antibiotics","score":0.7839999794960022},{"id":"https://openalex.org/keywords/gram-positive-bacteria","display_name":"Gram-positive bacteria","score":0.7149999737739563},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.8980000019073486},{"id":"https://openalex.org/keywords/vancomycin-resistant-bacteria","display_name":"vancomycin-resistant bacteria","score":0.7960000038146973},{"id":"https://openalex.org/keywords/protein-binding","display_name":"protein binding","score":0.6480000019073486},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.6069999933242798},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.6980000138282776},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.47999998927116394},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.675000011920929},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C2778651397","wikidata":"https://www.wikidata.org/wiki/Q418747","display_name":"Daptomycin","level":5,"score":0.9884358644485474},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.9308068752288818},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7122061848640442},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.5636416077613831},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5544275641441345},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5481255650520325},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.5027685165405273},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5023221969604492},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.42367759346961975},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4174472689628601},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.27708637714385986},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2545466423034668},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.12896475195884705},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003402","descriptor_name":"Creatine Kinase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017576","descriptor_name":"Daptomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017576","descriptor_name":"Daptomycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.47.4.1318-1323.2003","doi":"https://doi.org/10.1128/aac.47.4.1318-1323.2003","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.47.4.1318-1323.2003","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:112202","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC152488","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:12654665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12654665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:152488","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC152488/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:112202","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC152488","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1885067579","https://openalex.org/W1976868856","https://openalex.org/W1977251184","https://openalex.org/W1979827269","https://openalex.org/W2038306434","https://openalex.org/W2039563704","https://openalex.org/W2065724789","https://openalex.org/W2068687253","https://openalex.org/W2082442446","https://openalex.org/W2084775001","https://openalex.org/W2120575175","https://openalex.org/W2127704731","https://openalex.org/W2143084812","https://openalex.org/W2502670554"],"related_works":["https://openalex.org/W2151547308","https://openalex.org/W2045067168","https://openalex.org/W1979827269","https://openalex.org/W2059047234","https://openalex.org/W2254321024","https://openalex.org/W55764748","https://openalex.org/W1862412800","https://openalex.org/W198044254","https://openalex.org/W2334691277"],"abstract_inverted_index":{"The":[0,138,214,244],"purpose":[1],"of":[2,12,16,52,146,159,173,197,218,241,246,249],"this":[3],"paper":[4],"is":[5],"to":[6,29,58,83,182],"establish":[7],"the":[8,62,70,123,126,132,143,147,174,198,212,224,230,268],"pharmacokinetics":[9,87,109,245],"and":[10,31,49,68,92,96,105,128,171,216,229,238,265],"safety":[11],"escalating,":[13],"once-daily":[14,247],"doses":[15],"daptomycin,":[17],"a":[18,65,74,116,282],"novel":[19],"lipopeptide":[20],"antibiotic":[21],"active":[22],"against":[23],"gram-positive":[24],"pathogens,":[25],"including":[26],"those":[27],"resistant":[28],"methicillin":[30],"vancomycin.":[32],"This":[33],"phase":[34],"1,":[35],"multiple-dose,":[36],"double-blind":[37],"study":[38,71,148],"involved":[39],"24":[40,79,183],"healthy":[41],"subjects":[42,207,225],"in":[43,122,178],"three":[44,258],"dose":[45,134,283],"cohorts":[46],"(4,":[47],"6,":[48],"8":[50,287],"mg/kg":[51,288],"body":[53],"weight)":[54],"who":[55,208,226],"were":[56,98,152,221,234,263],"randomized":[57],"receive":[59],"daptomycin":[60,210,228,250,261],"or":[61],"control":[63,231],"at":[64,131,281],"3:1":[66],"ratio":[67],"administered":[69,278],"medication":[72],"by":[73,90,100],"30-min":[75],"intravenous":[76],"infusion":[77],"every":[78],"h":[80,184],"for":[81,223,289],"7":[82],"14":[84,290],"days.":[85,291],"Daptomycin":[86,108,188,271],"was":[88,110,195,204,251,272,277],"assessed":[89],"blood":[91],"urine":[93,179],"sampling.":[94],"Safety":[95],"tolerability":[97],"evaluated":[99],"monitoring":[101],"adverse":[102],"events":[103],"(AEs)":[104],"laboratory":[106],"parameters.":[107],"linear":[111,252],"through":[112,253],"6":[113,254],"mg/kg,":[114],"with":[115],"slight":[117],"(":[118,154,161,167,185],"approximately":[119,155,162,168,186],"20%)":[120],"nonlinearity":[121],"area":[124],"under":[125],"curve":[127],"trough":[129],"concentration":[130],"highest":[133],"studied":[135],"(8":[136],"mg/kg).":[137],"pharmacokinetic":[139],"parameters":[140],"measured":[141],"on":[142],"median":[144],"day":[145],"period,":[149],"(day":[150],"7)":[151],"half-life":[153],"9":[156],"h),":[157],"volume":[158],"distribution":[160],"0.1":[163],"liters/kg),":[164],"systemic":[165],"clearance":[166],"8.2":[169],"ml/h/kg),":[170],"percentage":[172],"drug":[175,199],"excreted":[176],"intact":[177],"from":[180],"0":[181],"54%).":[187],"protein":[189],"binding":[190],"(mean":[191],"amount":[192],"bound,":[193],"91.7%)":[194],"independent":[196],"concentration.":[200],"No":[201],"gender":[202],"effect":[203],"observed.":[205],"All":[206],"received":[209,227],"completed":[211],"study.":[213],"frequencies":[215],"distributions":[217],"treatment-emergent":[219],"AEs":[220,237],"similar":[222],"subjects.":[232],"There":[233],"no":[235,239],"serious":[236],"pattern":[240],"dose-related":[242],"events.":[243],"administration":[248],"mg/kg.":[255],"For":[256],"all":[257],"doses,":[259],"plasma":[260],"concentrations":[262],"consistent":[264],"predictable":[266],"throughout":[267],"dosing":[269],"interval.":[270],"well":[273],"tolerated":[274],"when":[275],"it":[276],"once":[279],"daily":[280],"as":[284,286],"high":[285]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":16},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":22},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
